AbbVie Inc. (ABBV): revenue growth, 5-year cagr, 10 filed years
Revenue CAGR 5y at AbbVie Inc. was 6.0% in FY2025, the newest filed year. Across the 10 computed years from FY2016 it ranged from 6.0% (FY2025) to 17.0% (FY2021), with a median of 10.9%.
Tonight's figure on the company page: 6.0%, recomputed 2026-10-15. The table is each filed year on its own terms, with the formula below; the current figure may use trailing twelve months or, where the explainer says so, a different denominator.
Year by year
| Fiscal year | Revenue CAGR 5y | Read from |
|---|---|---|
| FY2016 | 8.0% | 10-K, filed 2017-02-17 |
| FY2017 | 8.9% | 10-K, filed 2018-02-16 |
| FY2018 | 11.8% | 10-K, filed 2019-02-27 |
| FY2019 | 10.8% | 10-K, filed 2020-02-21 |
| FY2020 | 14.9% | 10-K, filed 2021-02-19 |
| FY2021 | 17.0% | 10-K, filed 2022-02-18 |
| FY2022 | 15.5% | 10-K, filed 2023-02-17 |
| FY2023 | 10.7% | 10-K, filed 2024-02-20 |
| FY2024 | 11.1% | 10-K, filed 2025-02-14 |
| FY2025 | 6.0% | 10-K, filed 2026-02-20 |
How each year is computed
(Revenue this year / revenue five fiscal years earlier)^(1/5) - 1, x 100
Each year is a ratio of lines in that year's filed annual report, with the nightly recompute's own rules for what counts as a filed line. Nothing is estimated, smoothed or filled in: a year that cannot be computed says why.
Read further
A computation on accounts filed with the SEC, not a recommendation and not advice. Past filings do not indicate future results. Risk disclaimer.